目的:探讨近红外荧光分子标记的凝集素样氧化低密度脂蛋白受体-1(LOX-1)抗体探针在ApoE-/-鼠主脉动脉粥样硬化近红外荧光(NIRF)成像中的可行性。方法:将ApoE-/-小鼠以高脂饮食喂养20周,建立动脉粥样硬化模型。将24只ApoE-/-动脉粥样硬化模型小鼠随机分为3组,即抗LOX-1抗体-NIR-797组、非特异性IgG-NIR-797组和单纯磷酸盐缓冲液(PBS)组,每组8只,分别经尾静脉注入抗LOX-1抗体-NIR-797、非特异性IgG-NIR-797和单纯PBS。另取8只C57BL/6小鼠作为对照组,经尾静脉注入抗LOX-1抗体-NIR-797,注入探针24h后取小鼠主动脉及主要脏器行NIRF成像,再取主动脉行油红O染色,比较NIRF成像面积和油红O染色面积比例的差异。结果:ApoE-/-小鼠经尾静脉注入抗LOX-1抗体-NIR-797探针24h后,NIRF成像显示有强荧光信号聚集于小鼠离体主动脉的斑块区域,而注入非特异性IgG-NIR-797组斑块区信号明显减弱,PBS组及对照组C57BL/6小鼠仅见较弱荧光信号,单因素方差分析结果显示差异有统计学意义(F=232,P<0.001)。NIRF阳性面积与斑块油红O染色面积比例分别为(42.70±1.25)%和(42.78±1.51)%,两者差异无统计学意义(t=0.409,P=0.695)。结论:近红外荧光分子标记的抗LOX-1抗体探针能够特异性地显示ApoE-/-鼠主动脉粥样硬化斑块的分布,可以作为小鼠动脉粥样硬化斑块成像的有效工具,LOX-1将来可能成为一个新的评价动脉粥样硬化的良好靶点。 |
[1] ROGER V L,GO A S,LLOYD-JONES D M,et al.Heart disease and stroke statistics—2012 update: a report from the American Heart Association[J].Circulation,2012,125(1): e2-e220.
[2] HE J,GU D,WU X,et al.Major causes of death among men and women in China[J].N Engl J Med,2005,353(11): 1124-1134.
[3] VANCRAEYNEST D,PASQUET A,ROELANTS V,et al.Imaging the vulnerable plaque[J].J Am Coll Cardiol,2011,57(20): 1961-1979.
[4] SANZ J,FAYAD Z A.Imaging of atherosclerotic cardiovascular disease[J].Nature,2008,451(7181):953-957.
[5] MITRA S,GOYAL T,MEHTA J L.Oxidized LDL,LOX-1 and atherosclerosis[J].Cardiovasc Drugs Ther,2011,25(5):419-429.
[6] REISS A B,ANWAR K,WIRKOWSKI P.Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis:a brief review[J].Curr Med Chem,2009,16(21):2641-2652.
[7] BRILEY-SAEBO K C,NGUYEN T H,SAEBOE A M,et al.In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes[J].J Am Coll Cardiol,2012,59(6):616-626.
[8] CHEN I Y,WU J C.Cardiovascular molecular imaging:focus on clinical translation[J].Circulation,2011,123(4):425-443.
[9] NAHRENDORF M,ZHANG H,HEMBRADOR S,et al.Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis[J].Circulation,2008,117(3):379-387.
[10] MORISHIGE K,KACHER D F,LIBBY P,et al.High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis[J].Circulation,2010,122(17):1707-1715.
[11] BRILEY-SAEBO K C,CHO Y S,SHAW P X,et al.Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes[J].Journal of the American College of Cardiology,2011,57(3):337-347.
[12] WEN S,X X,LIU D F,et al.OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice[J].J Lipid Res,2012,53(5):829-838.
[13] 卢瞳,文颂,周官辉,等.动脉粥样硬化斑块MRI和近红外分子影像的实验研究[J].中华核医学与分子影像杂志,2012,32(1):16-21.
[14] 王圆圆,姚玉宇,张毅,等.近红外荧光分子标记的ox-LDL靶向小鼠动脉粥样硬化模型的成像研究[J].东南大学学报:医学版,2011,30(4):588-593.
[15] NEWBY A C.Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability[J].Arteriosclerosis Thrombosis and Vascular Biology,2008,28(12):2108-2120.
[16] RAZAVIAN M,TAVAKOLI S,ZHANG J,et al.Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation[J].J Nucl Med,2011,52(11):1795-1802.
[17] OHSHIMA S,FUJIMOTO S,PETROV A,et al.Effect of an antimicrobial agent on atherosclerotic plaques:assessment of metalloproteinase activity by molecular imaging[J].J Am Coll Cardiol,2010,55(12):1240-1249.
[18] WALLIS de VRIES B M,HILLEBRANDS J L,van DAM G M,et al.Images in cardiovascular medicine multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe[J].Circulation,2009,119(20):e534-536.
[19] 姚琼,邓钢,吴国球,等.MMP-9单克隆抗体超微超顺磁性氧化铁粒子的合成并行ApoE-/-小鼠动脉粥样硬化7.0TMR成像的研究[J].东南大学学报:医学版,2011,30(3):431-435.
[20] 严雪娇,刘乃丰,吴国球.活体近红外成像技术在肿瘤研究中的应用[J].东南大学学报:医学版,2011,30(2):380-383.
[21] ISHINO S,MUKAI T,KUGE Y,et al.Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody:potential agent for imaging of vulnerable plaque[J].J Nucl Med,2008,49(10):1677-1685.
[22] LI D,PATEL A R,KLIBANOV A L,et al.Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance[J].Circ Cardiovasc Imaging,2010,3(4):464-472. |